Concert Pharmaceuticals Inc (NASDAQ:CNCE)

Delayed Data
As of Mar 21
 +0.40 / +2.33%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Concert Pharmaceuticals Inc have a median target of 26.00, with a high estimate of 27.00 and a low estimate of 17.00. The median estimate represents a +48.23% increase from the last price of 17.54.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Concert Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.17%
Growthannually -37.75%


Growthquarterly -100.00%
Growthannually -17.26%
Key to the earnings and sales forecast charts.